Agilent Technologies Inc. and Roche Establish Agreement to Provide Continued Service and Support to Roche NimbleGen, Inc Microarray Customers

Published: Nov 07, 2012

SANTA CLARA, Calif. & PENZBERG, Germany--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) and Roche (SIX: RO, ROG) (OTCQX: RHHBY) today announced the signing of an exclusive agreement to provide continued service to NimbleGen microarray customers as Roche phases out its NimbleGen array production and services.

Back to news